FILIP1L and cancer: To further test if epigenetic regulation results in re-expression of FILIP1L, we treated the four lowestFILIP1L-expressing cancer cell lines from each cancer histology (BT-549, HT-29, H1299 and MIA PaCa-2; Figure 1) with either a DNA demethylating agent or histone deacetylase inhibitor.